| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyCellularComponent | MCM complex | 1.94e-04 | 11 | 40 | 2 | GO:0042555 | |
| Domain | AAA+_ATPase | 3.11e-03 | 144 | 38 | 3 | IPR003593 | |
| Domain | AAA | 3.11e-03 | 144 | 38 | 3 | SM00382 | |
| Domain | Intermediate_filament_CS | 7.28e-03 | 63 | 38 | 2 | IPR018039 | |
| Domain | Filament | 9.17e-03 | 71 | 38 | 2 | SM01391 | |
| Domain | IF | 9.42e-03 | 72 | 38 | 2 | PS00226 | |
| Domain | Filament | 9.67e-03 | 73 | 38 | 2 | PF00038 | |
| Domain | IF | 1.04e-02 | 76 | 38 | 2 | IPR001664 | |
| Pubmed | Tumor type-dependent function of the par3 polarity protein in skin tumorigenesis. | 1.29e-06 | 2 | 40 | 2 | 22975380 | |
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 31358743 | ||
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 27452221 | ||
| Pubmed | Shared and independent functions of aPKCλ and Par3 in skin tumorigenesis. | 3.87e-06 | 3 | 40 | 2 | 29789715 | |
| Pubmed | The epidermal polarity protein Par3 is a non-cell autonomous suppressor of malignant melanoma. | 7.73e-06 | 4 | 40 | 2 | 28096290 | |
| Pubmed | 3.85e-05 | 332 | 40 | 5 | 25693804 | ||
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | 4.02e-05 | 1496 | 40 | 9 | 32877691 | |
| Pubmed | 4.62e-05 | 9 | 40 | 2 | 21074722 | ||
| Pubmed | CD44 regulates tight-junction assembly and barrier function. | 5.77e-05 | 10 | 40 | 2 | 21191420 | |
| Pubmed | 1.16e-04 | 14 | 40 | 2 | 34361001 | ||
| Pubmed | 1.30e-04 | 85 | 40 | 3 | 19028597 | ||
| Pubmed | 1.53e-04 | 16 | 40 | 2 | 33495473 | ||
| Pubmed | 1.79e-04 | 733 | 40 | 6 | 34672954 | ||
| Pubmed | Activity-based E3 ligase profiling uncovers an E3 ligase with esterification activity. | 1.81e-04 | 95 | 40 | 3 | 29643511 | |
| Pubmed | Comparative proteomic analysis of intra- and interindividual variation in human cerebrospinal fluid. | 1.95e-04 | 18 | 40 | 2 | 16199891 | |
| Pubmed | Huntingtin regulates mammary stem cell division and differentiation. | 1.95e-04 | 18 | 40 | 2 | 24749073 | |
| Pubmed | 1.95e-04 | 18 | 40 | 2 | 23487309 | ||
| Pubmed | 1.97e-04 | 251 | 40 | 4 | 28077445 | ||
| Pubmed | Tissue-Specific Regulation of the Wnt/β-Catenin Pathway by PAGE4 Inhibition of Tankyrase. | 2.13e-04 | 256 | 40 | 4 | 32698014 | |
| Pubmed | 2.45e-04 | 777 | 40 | 6 | 35844135 | ||
| Pubmed | 2.54e-04 | 497 | 40 | 5 | 23414517 | ||
| Pubmed | 2.67e-04 | 21 | 40 | 2 | 37422473 | ||
| Pubmed | mTORC1 and mTORC2 regulate skin morphogenesis and epidermal barrier formation. | 4.45e-04 | 27 | 40 | 2 | 27807348 | |
| Pubmed | 4.56e-04 | 313 | 40 | 4 | 20800603 | ||
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | 5.48e-04 | 588 | 40 | 5 | 38580884 | |
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | 5.89e-04 | 1284 | 40 | 7 | 17353931 | |
| Pubmed | SARS-CoV-2 uses Spike glycoprotein to control the host's anaerobic metabolism by inhibiting LDHB. | 6.33e-04 | 607 | 40 | 5 | 39147351 | |
| Pubmed | The splicing regulator Rbfox2 is required for both cerebellar development and mature motor function. | 6.66e-04 | 33 | 40 | 2 | 22357600 | |
| Pubmed | MKRN2 Physically Interacts with GLE1 to Regulate mRNA Export and Zebrafish Retinal Development. | 7.53e-04 | 358 | 40 | 4 | 32460013 | |
| Pubmed | 8.78e-04 | 653 | 40 | 5 | 22586326 | ||
| Pubmed | Cdc42 controls progenitor cell differentiation and beta-catenin turnover in skin. | 9.30e-04 | 39 | 40 | 2 | 16510873 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | 1.09e-03 | 1425 | 40 | 7 | 30948266 | |
| Pubmed | 1.13e-03 | 43 | 40 | 2 | 26030138 | ||
| CoexpressionAtlas | dev gonad_e11.5_F_PrimGermCell_Oct_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.57e-05 | 463 | 38 | 7 | gudmap_dev gonad_e11.5_F_PrimGermCell_Oct_k3_1000 | |
| ToppCell | CV-Severe-7|Severe / Virus stimulation, Condition and Cluster | 4.60e-07 | 177 | 39 | 5 | 82fdd6185b368f54f03de389427cbe3071d21a99 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.75e-05 | 178 | 39 | 4 | c77a1d1a9aef0ab51b4408b9e84f201219788ca2 | |
| ToppCell | facs-Kidney-nan-24m-Mesenchymal-kidney_interstitial_fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.87e-05 | 181 | 39 | 4 | 0ec9621a078d004bbd25a587757d24b5cf162959 | |
| ToppCell | facs-Kidney-nan-24m-Mesenchymal-kidney_interstitial_fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.87e-05 | 181 | 39 | 4 | c7f5aedcb74c21fb587a95a16d700e2a38a380ee | |
| ToppCell | CV-Moderate-7|Moderate / Virus stimulation, Condition and Cluster | 2.03e-05 | 185 | 39 | 4 | a6c9203ce6c2892a4a369c9bcfb85720f01cbb3f | |
| ToppCell | CV-Moderate-7|CV / Virus stimulation, Condition and Cluster | 2.08e-05 | 186 | 39 | 4 | 8571956890fc9894d766ba294a28e376b4aba428 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.12e-05 | 187 | 39 | 4 | 86250acf088ec0c4800a0dfa031b0d4f7e52c342 | |
| ToppCell | CD8+_Memory_T_cell-CV-7|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 2.30e-05 | 191 | 39 | 4 | 9454f642c3621370fa23640b631301346b300950 | |
| ToppCell | CV-Moderate-6|CV / Virus stimulation, Condition and Cluster | 2.55e-05 | 196 | 39 | 4 | 7bced0cc2112697593c478fa291b8ed3941fb811 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.76e-05 | 200 | 39 | 4 | b4ccffdd79526c85e5273d27b668dbddcddba1ee | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.76e-05 | 200 | 39 | 4 | 3dd022e974fec7013ba18f333da63f58fbf2dd7c | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_adventitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.76e-05 | 200 | 39 | 4 | 0c25d56292b9e5fefa4521b72635449be1ffd6fe | |
| ToppCell | mild-immature_Neutrophil|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.19e-04 | 109 | 39 | 3 | 2f03d6ee8b13424cc6a5bc60ac3461b44dff9d79 | |
| ToppCell | Myeloid-Myeloid-E_(Neutrophils)|Myeloid / shred on cell class and cell subclass (v4) | 3.04e-04 | 150 | 39 | 3 | 1bffb8d86b737ac43be902d9468041aef3542f1f | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-AT2_Progenitor|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.22e-04 | 153 | 39 | 3 | e7a074ea8232bacf924be78a244a8507c7e1ebc8 | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.28e-04 | 154 | 39 | 3 | 46155f36d3983f637b55d7525b675c8828f6ab2e | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.28e-04 | 154 | 39 | 3 | 71ffc23a2e02e27cabbdbeaa622e59e9f4a4cd9d | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c04-COTL1|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.74e-04 | 161 | 39 | 3 | bf4bfb416cb6ef43fc8cf0ffc2d7f0b6b42ab4da | |
| ToppCell | Club-club-13|World / Class top | 3.81e-04 | 162 | 39 | 3 | 7d18f05a65ac715e62d610df9cc4a26539340dee | |
| ToppCell | 390C-Myeloid-Dendritic-cDC_proliferating_2|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 4.02e-04 | 165 | 39 | 3 | a5c3af634d2698f9a01cf074791756b7669f9fff | |
| ToppCell | droplet-Pancreas-Exocrine-24m-Epithelial-pancreatic_acinar_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.02e-04 | 165 | 39 | 3 | 622aca1d49bd8c917b131e4f4959d9dba411d22b | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.16e-04 | 167 | 39 | 3 | 351f8de1fbdf742ac74f9099b254d515ab539bb2 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.16e-04 | 167 | 39 | 3 | c042d6cdddd0e1ddef1e3ac6f4fe23151127b0f2 | |
| ToppCell | droplet-Pancreas-Exocrine-24m-Epithelial-pancreatic_acinar_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.16e-04 | 167 | 39 | 3 | 3c06894fc6177f3c204094719904da42f08b9af8 | |
| ToppCell | Control|World / group, cell type (main and fine annotations) | 4.23e-04 | 168 | 39 | 3 | a3511faf2cd2c2b9c8363c8b99da3f3609c43ed6 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.38e-04 | 170 | 39 | 3 | a2c738e441ced90eeeb1fcc6ca3269b918aaa298 | |
| ToppCell | P07-Mesenchymal-mesenchymal_fibroblast-mesothelial_cell_of_visceral_pleura|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.53e-04 | 172 | 39 | 3 | 9a256db817c1af1802203cc88a55d608fb328c63 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.53e-04 | 172 | 39 | 3 | d354424c1f861b6607dfd63b9724f4c237b30275 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.53e-04 | 172 | 39 | 3 | bd01b39a5699824ab14827cc9dc98e547d65b160 | |
| ToppCell | Adult-Mesenchymal-pericyte_cell-D231|Adult / Lineage, Cell type, age group and donor | 4.53e-04 | 172 | 39 | 3 | 858cee96c1c06160863b4adcd7023c0d678bd50f | |
| ToppCell | Adult-Mesenchymal-pericyte_cell-D175|Adult / Lineage, Cell type, age group and donor | 4.61e-04 | 173 | 39 | 3 | fd6653d6be9ca6ac36798590694efe03cb758c67 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.61e-04 | 173 | 39 | 3 | 30d67738633493d47f06ae452424382f069b6c0a | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.69e-04 | 174 | 39 | 3 | 911eac6f6ec1e5e85348a7fe774243498388a810 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.69e-04 | 174 | 39 | 3 | a9c6edf5c3fc119c24425f921c5566a8356c30fe | |
| ToppCell | droplet-Marrow-nan-3m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.77e-04 | 175 | 39 | 3 | cf53a15bfb37b6019e7052ffdf594a9ac040900e | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c05-ZNF683|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.85e-04 | 176 | 39 | 3 | 5914e7635474e7cf24d446bdb1423bc0807ee9c6 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.85e-04 | 176 | 39 | 3 | 327a3e81b724252e36d786de92a3ffd721ea6d7b | |
| ToppCell | CV-Severe-7|CV / Virus stimulation, Condition and Cluster | 4.85e-04 | 176 | 39 | 3 | 3de0c7d77210049e5616db21eed1490a17a5ec2d | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.93e-04 | 177 | 39 | 3 | da8802a6351d3e510822f82e2fde8a4314a2216e | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.93e-04 | 177 | 39 | 3 | 452ec2df36c6d656a7cdadc55be545ccdb146a29 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.93e-04 | 177 | 39 | 3 | 7af1a19692f7fe8f691178a4e57d62bc379e3d56 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.01e-04 | 178 | 39 | 3 | 185b44700f06ec58b3c09c80520502166c965fd6 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.01e-04 | 178 | 39 | 3 | c413861148129be1ee94f2ceb5999840217eebe5 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6-Inh_L1_PAX6_CA4|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.01e-04 | 178 | 39 | 3 | e86ed30652c2de70f16430f04b78789b87df4af2 | |
| ToppCell | P28-Mesenchymal-mesenchymal_fibroblast-mesothelial_cell_of_visceral_pleura|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.01e-04 | 178 | 39 | 3 | 1e05bc26591fea16e29bcfc5f538dda1dc427f05 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.01e-04 | 178 | 39 | 3 | bcbdd45a2307f8aea14122fa0144b96b1f6eec48 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.09e-04 | 179 | 39 | 3 | 88d44b04eb5c079531db663ed98ddb20b60feb9a | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_2-AT2_Progenitor|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.09e-04 | 179 | 39 | 3 | 7db6b97a1c4c7a163d5da4351ba36ac1785d9d7b | |
| ToppCell | P03-Mesenchymal-mesenchymal_fibroblast-mesothelial_cell_of_visceral_pleura|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.18e-04 | 180 | 39 | 3 | 2ccc77d769d3ffd77ab3af45e4f192785b6db79c | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.18e-04 | 180 | 39 | 3 | f6a2208960d0df1500c974cc44c3c054cd7475a9 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.26e-04 | 181 | 39 | 3 | 451b87ac95154bb80018b8dd245b4a6389d81411 | |
| ToppCell | facs-Marrow-T-cells-3m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.26e-04 | 181 | 39 | 3 | 57f0cc749ae8b6a3d77e2af31f9a6e4739c57049 | |
| ToppCell | facs-Marrow-T-cells-3m-Hematologic-hematopoietic_stem_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.26e-04 | 181 | 39 | 3 | d01b35cc2fc57991a35be6a06cb7351fbabd9a11 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD8-Trm/em_CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 5.35e-04 | 182 | 39 | 3 | f857b32de19240a8aca1685f7a78b4e53b04875c | |
| ToppCell | COPD-Epithelial-ATII|World / Disease state, Lineage and Cell class | 5.43e-04 | 183 | 39 | 3 | 8e9aab4eeec2e282c2cab9bfca6dbf40d660c7b9 | |
| ToppCell | Adult-Mesenchymal-pericyte_cell-D122|Adult / Lineage, Cell type, age group and donor | 5.43e-04 | 183 | 39 | 3 | fc31a43a637423cb3bb9aa184a3a889a0b9aaea6 | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.52e-04 | 184 | 39 | 3 | c9d7ec17cc5b7ba1b1e721ca392746e8f4a3d41f | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_2-AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.52e-04 | 184 | 39 | 3 | 157a3d00165bb4a8c52c3e63ae57d9cf57500be7 | |
| ToppCell | COVID-19-Fibroblasts-Pericytes|COVID-19 / group, cell type (main and fine annotations) | 5.61e-04 | 185 | 39 | 3 | 4905adaeeffd353e089578e5ea614437dbe794e6 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_2-AT2_Progenitor|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.61e-04 | 185 | 39 | 3 | 929b68b05b7686341329ac756d7df172cb4b810b | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.61e-04 | 185 | 39 | 3 | a7dba7db79275884b2a93d8a16f2e0c739e71370 | |
| ToppCell | COVID-19-Fibroblasts-Adventitial_FB|COVID-19 / group, cell type (main and fine annotations) | 5.61e-04 | 185 | 39 | 3 | a5aebf2b9b05b550d021272731d68af9a6b1229d | |
| ToppCell | COPD-Stromal-Pericyte|World / Disease state, Lineage and Cell class | 5.69e-04 | 186 | 39 | 3 | 8adfd2d1fda4e8aecc95192ea627bf7ed5214b8d | |
| ToppCell | E12.5-Mesenchymal-mesenchymal_fibroblast-mesothelial_cell_of_visceral_pleura|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.69e-04 | 186 | 39 | 3 | 1587667e5084ac43505d027af925ba711e228150 | |
| ToppCell | LPS_only-Epithelial_alveolar|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.69e-04 | 186 | 39 | 3 | e0a2ea4b46af742bc7c9b2072bb85e27d5c92712 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.69e-04 | 186 | 39 | 3 | 888e85a025bd982d36c910db0f5a3385b1ca3b28 | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-basal_cell_of_epidermis|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.78e-04 | 187 | 39 | 3 | 9c1013720c248ef201d010806b6e7ad24205e8ee | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.78e-04 | 187 | 39 | 3 | ff26a533d310126521efe1d05cf8b9d32e524550 | |
| ToppCell | mild_COVID-19-CD4+_CTL|mild_COVID-19 / disease group, cell group and cell class (v2) | 5.78e-04 | 187 | 39 | 3 | 49196d07e4716c87d33229a4569bdb6b4613b3eb | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.78e-04 | 187 | 39 | 3 | fa01a61bfd13feb033ba1e35cf513707b1bff8c8 | |
| ToppCell | Adult-Mesenchymal-pericyte_cell|Adult / Lineage, Cell type, age group and donor | 5.78e-04 | 187 | 39 | 3 | 62759efb660179402fb574ce5701c89a2e17bcfe | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.78e-04 | 187 | 39 | 3 | 201ff693e4756ee3e44762885b3a303a77eb535b | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_NK-NK_dim-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 5.78e-04 | 187 | 39 | 3 | 0bca79cea4886b66350c56c61859bd71e1e7a85c | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.78e-04 | 187 | 39 | 3 | a2bf958ea59c359a265bfa437d59315e1920cdd4 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.87e-04 | 188 | 39 | 3 | 4bdf8d49af0e9da349b16e3f012e1b0eec04cc4f | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.87e-04 | 188 | 39 | 3 | 63a4b25a0a6e05f80f1a6dd91b817f3cf49e6b68 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.87e-04 | 188 | 39 | 3 | ee151792c7ac9afe820f1a281c6dab383799f358 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.87e-04 | 188 | 39 | 3 | ccddc08121caff958a2b6f9e278a018858af6b4d | |
| ToppCell | droplet-Lung-nan-21m-Lymphocytic-Proliferating_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.87e-04 | 188 | 39 | 3 | 61ae7405ab56570409bf35382dc0a038e4137c15 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.87e-04 | 188 | 39 | 3 | 43a0508d2524a5b310e89e9422843dcaab999bc3 | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-Basal_IFE|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.87e-04 | 188 | 39 | 3 | 8cc927b4c51d982fdafa04dc7393617ad9bb220e | |
| ToppCell | Mesenchymal-pericyte_cell|World / Lineage, Cell type, age group and donor | 5.97e-04 | 189 | 39 | 3 | d7ed96add29f219183c802895fbff519b627f635 | |
| ToppCell | tumor_Lung-Fibroblasts-Pericytes|Fibroblasts / Location, Cell class and cell subclass | 5.97e-04 | 189 | 39 | 3 | 9c407b17d7945e81e1ae6c18452f5d20fb09d563 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.97e-04 | 189 | 39 | 3 | 7ab1cfc1657277858339f7258a0c4ae9cb42fdf8 | |
| ToppCell | normal_Lung-Fibroblasts-Undetermined|normal_Lung / Location, Cell class and cell subclass | 6.06e-04 | 190 | 39 | 3 | 30d4658bcc6796f0cdf54cc029f4bb904b13ef66 | |
| ToppCell | IPF-Epithelial-Basal|IPF / Disease state, Lineage and Cell class | 6.06e-04 | 190 | 39 | 3 | ea19e9ce954f2dfde97388db9695325cd92ab88f | |
| ToppCell | 15-Distal-Mesenchymal-Mesenchyme_SERPINF1-high|Distal / Age, Tissue, Lineage and Cell class | 6.06e-04 | 190 | 39 | 3 | b47472dc9fe6ed99c2365203a3d8a59879e74a70 | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_1-Pericyte|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.06e-04 | 190 | 39 | 3 | 4eb92aef1ee868f4537483d19014d947b7684612 | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.06e-04 | 190 | 39 | 3 | 7be4341e2909101d756f14031c21e705eb45e69a | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 6.06e-04 | 190 | 39 | 3 | e83fa8b711aa79a1767818474f1c193b674b1c31 | |
| ToppCell | pdx-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 6.06e-04 | 190 | 39 | 3 | d06ee5f89f1cec8db6897fe3b2a890a07cd3697b | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.06e-04 | 190 | 39 | 3 | 078f4be52fa4cc8dd9c8d7a2b6d9631c3d902285 | |
| ToppCell | facs-Pancreas-Endocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.15e-04 | 191 | 39 | 3 | f76f3f5c7902a3659d8cbe470f96ce57c8a6744d | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 6.15e-04 | 191 | 39 | 3 | fa380a8752de158974b2ae5e741573439719cc0d | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.15e-04 | 191 | 39 | 3 | 7853ac7dff649150e6ff27cd4c8cf7c1fc034ed4 | |
| ToppCell | droplet-Lung-21m-Hematologic-lymphocytic-Proliferating_T_cell-proliferating_T|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.15e-04 | 191 | 39 | 3 | 15dbc5a03bfab8931c0fd385b0f25874736ae874 | |
| ToppCell | 5'-Adult-LymphNode-Mesenchymal|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.15e-04 | 191 | 39 | 3 | 054e9a79bd1486fd812bc7418fb091664fe3a646 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.15e-04 | 191 | 39 | 3 | 716dfa7fccbd62b5f574792e68a26dc6c45511dc | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.15e-04 | 191 | 39 | 3 | 1b26056df078674f37a6c06f6256b30cfcec21a7 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.15e-04 | 191 | 39 | 3 | 08042952431ca1a6fd7dfc13f36eb28643979598 | |
| Drug | pulegones | 6.05e-06 | 21 | 39 | 3 | CID000006988 | |
| Drug | 4-phenylthiosemicarbazide | 8.57e-06 | 3 | 39 | 2 | CID000730679 | |
| Disease | Emery-Dreifuss muscular dystrophy (implicated_via_orthology) | 1.06e-04 | 12 | 38 | 2 | DOID:11726 (implicated_via_orthology) | |
| Disease | estradiol measurement | 3.87e-04 | 110 | 38 | 3 | EFO_0004697 | |
| Disease | lipoprotein-associated phospholipase A(2) measurement | 1.22e-03 | 40 | 38 | 2 | EFO_0004746 | |
| Disease | hemolysis | 1.68e-03 | 47 | 38 | 2 | EFO_0009473 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KGQHALLNEGEENEM | 6 | Q4VNC1 | |
| NKMFSRHNEGDDQQG | 256 | Q9UKT5 | |
| HQEMIGGLRNNNEKD | 1126 | P01024 | |
| GDGRDEEIAAKQHNM | 536 | Q99504 | |
| QKGNMEVARIHAENA | 41 | Q7LBR1 | |
| GIDEFDKMGNQHQAL | 516 | Q9UJA3 | |
| AARNGMKNQFNLHEL | 436 | P51654 | |
| KNHEEEMNALRGQVG | 251 | P02533 | |
| HLGQMGQDEMQRLEN | 1226 | Q6ZRQ5 | |
| DIMDLDQGQRLNNGA | 1211 | Q9ULI0 | |
| QRVQEGKDSAHLMNG | 16 | Q92615 | |
| DEKGNDLGNMHRANV | 91 | Q9H2K0 | |
| KQLEEHMNTGQLAGF | 2106 | P50748 | |
| IGLNREQMALNHGEE | 96 | P07738 | |
| RKEDGMENLKNHDNN | 271 | Q96JA3 | |
| GMNGIQKFQIHRDDR | 4316 | Q7Z6Z7 | |
| GFMQGHVNRQEKEEK | 421 | Q9H2U1 | |
| GNEGNQEMLQEIKNR | 861 | Q86WZ0 | |
| ENHRQLQARMGDLKG | 456 | Q9Y2G2 | |
| RAHAVDMNGNKVENP | 246 | P55283 | |
| QHENKMLRLQQEGSE | 471 | Q9UJC3 | |
| LGEGHHRVQENQMDK | 441 | P05060 | |
| LLGQHNDEMQELSGN | 316 | Q68D86 | |
| DMRGNPGQSLQHKEN | 296 | Q8WZA6 | |
| SHSLERQMNGNQEKG | 971 | Q8TEW0 | |
| VEEEMQKHGSNNVGL | 341 | Q6S8J7 | |
| GQQMKELRAQHEENI | 166 | Q6P4E1 | |
| EQVSQEVHQGLKDMG | 286 | Q5H9J9 | |
| RALHDKQLNMQGTAQ | 6181 | Q8NF91 | |
| EGDQAHREQGKEQAM | 1511 | O15061 | |
| GQNHQGDLDVAKRMI | 26 | Q9NR45 | |
| VKQQGLRQDHPGQMD | 4311 | Q63HN8 | |
| LLMQQEERAKQQGDH | 156 | Q13435 | |
| NGDQHGNMVRVVAKN | 391 | Q6NUS8 | |
| VHEARMENGQRKQDN | 441 | Q9NXZ1 | |
| KKHDIMIQENGNGLE | 481 | Q06203 | |
| RKINHEMANGGNQNL | 396 | P53804 | |
| LQQIGVDMDKIHGQA | 701 | Q5SVZ6 | |
| RNKHIMIDLGTGNNN | 86 | P83876 | |
| MGQNALQLAVGNEHL | 61 | Q13507 |